Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.71, $0.07 better than the analyst estimate of $2.64. Revenue for the quarter came in at $21.38 billion versus the consensus estimate of $21.4 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.